Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis
Authors:
- 1 August 2006
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 65 (8) , 990-997
Abstract
Objectives: To determine the impact on synovial histopathology of changes in clinical disease activity in the absence of effective treatment. Methods: Twelve patients with active RA not receiving effective treatment were studied over a 14 week period. Synovial biopsy specimens obtained at baseline and week 14 were analysed by histology and immunohistochemistry. Results: Over the course of 14 weeks, there was a trend towards a decrease of the DAS28, with 7/12 patients being good or moderate DAS28 responders despite the absence of effective treatment. Patients’ assessment of global disease activity and swollen joint count both decreased significantly. Histologically, there was a decrease of lining layer hyperplasia and lymphoid aggregates, a similar trend for vascularity, but there was no effect on global synovial infiltration. Accordingly, there was no decrease of the cellular infiltration with T lymphocytes (CD3, CD4, CD8), B lymphocytes (CD20), plasma cells (CD38), dendritic cells (CD1a, CD83), and even an increase of CD163+ sublining macrophages, with a similar trend for CD68+ sublining macrophages. The changes in DAS28 scores in these patients did not correlate with changes in histological variables, with the exception of an inverse correlation with plasma cells. Remarkably, even in the DAS28 responders, no significant changes in synovial inflammatory infiltration were noted. Conclusions: Despite variations in global disease activity, synovial inflammatory infiltration did not change significantly in the absence of effective treatment. The lack of a placebo effect on synovial markers of treatment response such as sublining macrophages can facilitate conclusive early phase trials with small numbers of patients with RA.Keywords
This publication has 42 references indexed in Scilit:
- Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow upAnnals of the Rheumatic Diseases, 2004
- Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodiesArthritis & Rheumatism, 2001
- Validation of rheumatoid arthritis improvement criteria that include simplified joint counts1998
- Asymptomatic synovitis precedes clinically manifest arthritisArthritis & Rheumatism, 1998
- Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritisRheumatology, 1998
- Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activityArthritis & Rheumatism, 1997
- Expression of Adhesion Molecules in Early Rheumatoid Synovial TissueClinical Immunology and Immunopathology, 1995
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988